Related Content
Clinical Trials
GSK and Innoviva Present Positive Results from Pioneering Asthma Study
PAO-M09-17-NI-020
Contributing Authors
Peter Cramer, AIA, NCARB, LEED AP, is VP Life Science Facility Design at M+W Group with more than 25 years of industry-leading experience in preparing conceptual and basis of design documents for pharmaceutical and biologics clients. He is a leader in designing cGMP-manufacturing facilities for clients around the globe. A facility design subject matter expert and contributing member to ISPE, Peter is a thought leader who specializes in the planning and design of facilities using disposable-single-use and modular technologies.
